Skip to main content
. 2025 Aug 23;45(1):124. doi: 10.1007/s10875-025-01912-z

Table 1.

Clinical features of the 27 patients with hereditary angioedema (HAE)

Clinical features HAE-1/2
(n = 19)
HAE-nC1-INH
(n = 8)
p-value Total
(n = 27)
Females(%) 14 (73.68%) 4 (50%) 0.375 18 (66.67%)
At first event(years), mean ± SD 19.79 ± 8.88 39.95 ± 14.41 0.034* 25.76 ± 14.09
At diagnosis(years), mean ± SD 32.14 ± 14.01 46.08 ± 15.68 0.789 36.27 ± 15.62
Delay in diagnosis(years), median(IQR) 12 (1,22) 1.75 (0.90,1.83) 0.333 8 (1,19)
Family history of HAE(%) 14 (73.68%) 1(12.5%) 0.008* 15 (55.56%)
Genomic variant
SERPING1 12 0 / 12
FXII 0 1 / 1
KNG1 0 2 / 2
MYOF 1 4 / 5
HS3ST6 0 1 / 1
Not checked 7 0 / 7
Clinical manifestations
Skin/extremities/trunk 19 8 / 27
Gastrointestinal tract 11 3 0.420 14
Laryngeal 12 3 0.398 15
Persistent swelling 0 3 0.019* 3
Prodromal symptoms
Erythema or erythema marginatum 5 1 0.633 6
Tiredness and fatigue 2 0 1.000 2
Trigger factors
Trauma/compression 7 0 0.062 7
Stress/emotional factors 6 3 1.000 9
Infection 2 0 1.000 2
Cold weather 3 0 0.532 3
Around menstruation/Oral contraceptive 4 0 0.285 4
Exposure to specific foods or chemicals (i.e. persimmons, seafood, alcohol) 3 1 1.000 4
Comorbidities
Allergic diseases 5 6 0.033* 11
Autoimmune diseases 5 2 1.000 7
Simultaneous attacks of edema and pruritic rashes (i.e. urticaria) 1 3 0.081 4

*For the categorical variables, the p-vaule was obtained from chi-square test, with Fisher’s exact test applied when expected frequencies in any cell were less than five. For continuous variables, the p-vaule was obtained from independent samples t-tests for normally distributed data or the Mann-Whitney U test for non-normally distributed data